Yuriy Borshchev | Ischemic-reperfusion injury | Best Researcher Award

Dr. Yuriy Borshchev | Ischemic-reperfusion injury | Best Researcher Award

Almazov National Medical Research Center | Russia

Author Profile:

Scopus

Orcid

🏅 BEST RESEARCHER PROFILE: DR. YURIY BORSHCHEV

👨‍🎓 EARLY ACADEMIC PURSUITS

Dr. Yuriy Borshchev was born on April 13, 1968, in Chisinau, Republic of Moldova. His academic journey began at Chisinau State University, where he pursued his studies from 1985 to 1992 in the Faculty of Biology and Soil Science, majoring in Biology with a specialization in Human and Animal Physiology. This foundational education laid the groundwork for his future contributions to physiological and biomedical research.

💼 PROFESSIONAL ENDEAVORS

Before fully immersing himself in academia, Dr. Borshchev gained extensive practical experience in various industries. Between 1992 and 2007, he worked in mechanical engineering and food processing enterprises in Moldova, advancing from logistics roles to leadership positions such as enterprise director. In 2007, he transitioned into scientific research, joining the Pavlov Institute of Animal Physiology as a laboratory assistant and later as a research associate.

By 2012, he earned his PhD (Candidate of Biological Sciences) with a dissertation focused on the effects of probiotic bacteria on intestinal enzymes in rats with dysbiosis. His career progressed as he became a senior researcher at the Institute of Experimental Medicine and, later, the Almazov National Medical Research Center, where he now serves as Head of the Physiological Microendoecology Department.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ISCHEMIC-REPERFUSION INJURY

Dr. Borshchev's work sits at the intersection of cardiology, gastroenterology, microbiology, and pathophysiology. His key contributions include:

  • Development of novel experimental biomedical models for studying inflammation and metabolic disorders.

  • Creation of a systemic inflammatory response model in rats, used to evaluate the therapeutic potential of probiotic bacteria.

  • Pioneering research into the influence of intestinal microbiota on myocardial resistance to ischemia-reperfusion injury.

  • Broad expertise in biochemical, histological, microbiological, and behavioral methodologies, as well as surgical experimentation on lab animals.

🌍 IMPACT AND INFLUENCE

Dr. Borshchev has significantly contributed to experimental medicine through:

  • Over 70 scientific publications, including 40 in SCI/SCIE journals and 18 indexed in Scopus/Web of Science/PubMed.

  • An H-index of 5, with a citation count of 22, reflecting ongoing recognition in specialized fields.

  • 8 completed research projects and 2 ongoing, amounting to over $800,000 USD in funding.

  • 5 industry-sponsored consultancy projects, demonstrating applied research impact.

  • Author and contributor to 8 books and proceedings with ISBNs.

  • One patent published, highlighting innovation in translational medical science.

📚 ACADEMIC CITES AND LEADERSHIP

In his academic and professional capacity, Dr. Borshchev:

  • Has served in editorial and reviewer roles for 2 journals/conferences.

  • Delivered 4 invited talks, attended 15 conferences, and visited 4 countries for international collaboration.

  • Supervised and graduated 2 research scholars, and is actively involved in collaborative scientific projects.

  • Maintains active profiles in global databases:

    • Scopus Author ID: 57206730176

    • Web of Science Researcher ID: IDE-1363-2014

    • elibrary.ru SPIN-code: 3454-4113

🧪 LEGACY AND FUTURE CONTRIBUTIONS

As a leading scientist at the Almazov National Medical Research Center, Dr. Borshchev continues to push the boundaries of experimental and translational medicine. His legacy is built on:

  • Bridging microbial ecology and systemic physiology.

  • Advancing knowledge in cardio-gastrointestinal interactions.

  • Training the next generation of scientists and building collaborative international partnerships.

Looking forward, Dr. Borshchev aims to expand his department's work into oncopharmacology and metabolic disease modeling, with the potential to influence both clinical therapies and preclinical standards.

🏆 AWARDS AND PROFESSIONAL AFFILIATIONS

Dr. Borshchev has been honored with 4 research awards, and holds 2 professional body memberships. He is committed to ethical research, demonstrated by his GLP-certified training in preclinical study protocols and laboratory animal handling.

🤝 COLLABORATIONS AND NETWORKING

  • 2 active MoUs with universities/industries.

  • 2 joint collaborative publications/projects.

  • Contributed to scientific communities across Russia, Europe, and other research-focused regions.

📌 CONCLUSION

Dr. Yuriy Borshchev exemplifies the qualities of a Best Researcher Award recipient: innovative, dedicated, and globally engaged. His work stands out for its relevance, depth, and potential to influence medical science well into the future.

📑 NOTABLE PUBLICATIONS

"Brain-Derived Neurotrophic Factor Cancels the Cardioprotective Effect of Interleukin-2 in a Model of Systemic Inflammatory Response in Rats"

Authors: I.Y., Burovenko, Inessa Yu , Y.Y., Borshchev, Yury Yu , S.M., Minasyan, Svetlana M. , ... O.V., Borshcheva, Olga V. , M.M., Galagudza, Mikhail M.
Journal: Bulletin of Experimental Biology and Medicine
Year: 2025

"Changes in the activity of amylase, alkaline phosphatase and lipase in placenta and umbilical cord blood in women in labor with gestational diabetes mellitus"

Authors: Elena V. Kolodkina; Sergey A. Lytaev; Michael M. Galagudza; Alexander B. Loginov; Tatyana M. Pervunina; Stanislav I. Sitkin; Yuri Yu. Borschchev; Olga V. Borschcheva
Journal: Medical academic journal
Year: 2025

Chunna Jin | Heart Failure | Best Researcher Award

Dr. Chunna Jin | Heart Failure | Best Researcher Award

Dr. Chunna Jin is the Associate Chief Physician at the Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhejiang University, China. She holds a Ph.D. in Cardiovascular Medicine from The Chinese University of Hong Kong and completed her postdoctoral fellowship at St. Francis Hospital, New York, USA. With a strong focus on ischemic heart disease, heart failure, and cardiovascular imaging, Dr. Jin combines advanced clinical expertise with cutting-edge research. She has published extensively in high-impact journals and is recognized for her international collaborations and contributions to innovative, patient-centered cardiovascular care.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Chunna Jin embarked on her academic journey with a profound interest in cardiovascular health. Her early dedication to medicine led her to pursue advanced studies in one of Asia’s top medical institutions. She earned her Ph.D. in Cardiovascular Medicine from the Faculty of Medicine, The Chinese University of Hong Kong (CUHK), where she laid the foundation for her clinical expertise and scientific research. This phase of her education not only enriched her clinical understanding but also honed her analytical skills, preparing her for a dynamic career in medicine.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Jin serves as an Associate Chief Physician at the Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhejiang University (ZUCC) in China. In this pivotal role, she combines her clinical acumen with innovative medical practices to deliver high-quality cardiovascular care. Her career also includes international exposure as a Postdoctoral Research Fellow at St. Francis Hospital in New York, USA, a renowned center for cardiovascular treatment and research. This experience broadened her global perspective and deepened her understanding of diverse healthcare systems.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON HEART FAILURE:

Dr. Jin’s research is focused on cardiovascular diseases, with a particular interest in ischemic heart conditions, heart failure, and minimally invasive interventions. She has contributed extensively to studies involving cardiovascular pharmacotherapy, echocardiographic techniques, and electrophysiological diagnostics. Her interdisciplinary approach integrates clinical trials, translational medicine, and patient-centered innovations, contributing to a deeper understanding of heart health at both cellular and systemic levels.

🌍 IMPACT AND INFLUENCE:

Through her work, Dr. Jin has significantly influenced both clinical practice and academic research in cardiovascular medicine. Her international collaborations and her leadership at ZUCC have helped introduce cutting-edge diagnostic and therapeutic protocols into clinical settings. She is regarded as a mentor and guide by younger professionals in the field, and she has played a vital role in enhancing healthcare standards through training and development initiatives.

📚 ACADEMIC CITES AND PUBLICATIONS:

Dr. Jin has authored and co-authored numerous peer-reviewed journal articles, case reports, and conference papers, many of which are frequently cited in cardiovascular research. Her work appears in leading journals such as the European Heart Journal, Journal of the American College of Cardiology (JACC), and Circulation. These contributions have not only gained academic recognition but also have direct clinical applications that benefit patients worldwide.

🏅 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Chunna Jin’s legacy is defined by her dedication to clinical excellence, innovative research, and global collaboration. Moving forward, she aims to pioneer personalized treatment models for cardiovascular patients, integrating genomic data and AI-driven diagnostics into mainstream medicine. Her vision includes fostering international research networks, enhancing telecardiology, and contributing to global health policy on cardiovascular disease prevention.

⭐CONCLUSION:

Dr. Chunna Jin is a trailblazing leader in cardiovascular medicine whose dedication to clinical excellence and research innovation continues to make a global impact. Her journey from prestigious academic institutions to influential hospital roles reflects her unwavering commitment to improving heart health. With a passion for mentoring, international collaboration, and advancing medical science, Dr. Jin stands as a role model for future healthcare professionals. Her ongoing efforts in precision medicine and digital healthcare promise a brighter, healthier future for cardiovascular patients worldwide. Dr. Jin’s legacy is one of compassion, expertise, and visionary progress.

TOP NOTABLE PUBLICATIONS

Association between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure

  • Authors: Senmiao Chen, Guanzhong Chen, Yu Jin, Shiyu Zhu, Liangliang Jia, Chengchen Zhao, Chunna Jin, Meixiang Xiang

  • Journal: Journal of Diabetes Investigation

  • Year: 2024

First-Phase Ejection Fraction to Predict Adverse Outcomes in Patients with Heart Failure

  • Authors: Chunna Jin, Guanzhong Chen, Senmiao Chen, Hong Ma, Meixiang Xiang

  • Journal: International Journal of Cardiology

  • Year: 2024